survey on the effect of antioxidant supplement on improvement of different symptom in covid-19 patient

Phase 2

Recruiting

• Conditions: Covid-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20160625028622N2
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

A positive PCR test for a new coronavirus
Having an involvement in a CT scan of the lungs and a definitive diagnosis by the treating physician that the person is infected
Therefore, people whose confirmed results of this virus are confirmed and who have 2 or more of the following symptoms will be studied in the following study: Including: Patients with pulmonary involvement of 50% and above (severe cases) (sometimes closed At the discretion of the physician and the patient's condition, lower lung involvement is also a criterion for hospitalization (moderate cases), 90 <O2 saturation <94 (moderate to severe cases) and o2 saturation <90 (severe cases), sub-cough symptoms (visual assessment criteria) Sore throat (patient report), headache (patient report), nasal congestion (patient report), fever (temperature above 37.3), body aches and pains (patient report), fatigue (patient report)

Exclusion Criteria

Patients suspected of having a bacterial respiratory infection at the beginning of the study
Patients with serious chronic diseases.
Pregnant women
Patients with HIV
Patients with cancer
Patients with vascular disease
Patient with endocrine disease
Patients who become infected during studying

Study & Design

• Study Type: interventional
• Study Design: Not specified